CRNC vs. EDIT
CRNC (Cerence Inc.) and EDIT (Editas Medicine, Inc.) are both stocks. CRNC operates in Software - Application (Technology), while EDIT operates in Biotechnology (Healthcare). Over the past 5 years, CRNC returned -39.77%/yr vs -42.73%/yr for EDIT. Their 0.36 correlation means their historical movements had little consistent relationship.
Performance
CRNC vs. EDIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRNC achieves a -20.30% return, which is significantly lower than EDIT's 25.85% return.
CRNC
- 1D
- 2.77%
- 1M
- -20.45%
- 6M
- -24.80%
- YTD
- -20.30%
- 1Y
- 4.67%
- 3Y*
- -32.58%
- 5Y*
- -39.77%
- 10Y*
- —
- ALL TIME*
- -9.77%
EDIT
- 1D
- -4.09%
- 1M
- -29.32%
- 6M
- 29.65%
- YTD
- 25.85%
- 1Y
- 5.74%
- 3Y*
- -33.19%
- 5Y*
- -42.73%
- 10Y*
- -20.31%
- ALL TIME*
- -16.91%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CRNC Cerence Inc. | $6.72M | $6.45M | $10.74M |
| $3.37M | $6.15M | $7.58M |
CRNC vs. EDIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
CRNC Cerence Inc. | -20.30% | 36.18% | -60.07% | 6.10% | -75.82% | -23.73% | 344.01% | 31.65% |
EDIT Editas Medicine, Inc. | 25.85% | 61.42% | -87.46% | 14.21% | -66.59% | -62.13% | 136.78% | 34.35% |
Correlation
The correlation between CRNC and EDIT is 0.26, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.26 |
Correlation (3Y) Balances recent behavior with more history. | 0.32 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.37 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2019 | 0.36 |
The correlation between CRNC and EDIT shifts across timeframes, from 0.26 (1 year) to 0.37 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CRNC:
$385.00M
EDIT:
$252.58M
CRNC:
-$0.44
EDIT:
-$1.18
CRNC:
1.27
EDIT:
6.64
CRNC:
2.52
EDIT:
57.29
CRNC:
$302.14M
EDIT:
$35.86M
CRNC:
$235.95M
EDIT:
$35.86M
CRNC:
$34.08M
EDIT:
-$76.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRNC vs. EDIT — Risk / Return Rank
CRNC
EDIT
CRNC vs. EDIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cerence Inc. (CRNC) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRNC | EDIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.12 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.09 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.02 | 0.05 | -0.06 |
| Martin ratioReturn relative to average drawdown | -0.03 | 0.08 | -0.11 |
Loading charts...
Drawdowns
CRNC vs. EDIT - Drawdown Comparison
The maximum CRNC drawdown since its inception was -98.22%, roughly equal to the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for CRNC and EDIT.
Loading charts...
Drawdown Indicators
| CRNC | EDIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.22% | -98.92% | +0.70% |
Max Drawdown (1Y)Largest decline over 1 year | -55.92% | -59.88% | +3.96% |
Max Drawdown (3Y)Largest decline over 3 years | -91.15% | -91.18% | +0.03% |
Max Drawdown (5Y)Largest decline over 5 years | -98.02% | -98.66% | +0.64% |
Max Drawdown (10Y)Largest decline over 10 years | — | -98.92% | — |
Current DrawdownCurrent decline from peak | -93.61% | -97.15% | +3.54% |
Average DrawdownAverage peak-to-trough decline | -63.70% | -63.06% | -0.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.24% | 34.68% | -6.44% |
Volatility
CRNC vs. EDIT - Volatility Comparison
Cerence Inc. (CRNC) and Editas Medicine, Inc. (EDIT) have volatilities of 20.56% and 19.89%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRNC | EDIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.56% | 19.89% | +0.67% |
Volatility (6M)Calculated over the trailing 6-month period | 61.10% | 62.54% | -1.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 86.36% | 90.40% | -4.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.06% | 93.71% | +20.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 105.92% | 83.98% | +21.94% |
Dividends
CRNC vs. EDIT - Dividend Comparison
Neither CRNC nor EDIT has paid dividends to shareholders.
Financials
CRNC vs. EDIT - Financials Comparison
This section allows you to compare key financial metrics between Cerence Inc. and Editas Medicine, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRNC and EDIT have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRNC has higher volatility (20.56%) compared to EDIT (19.89%). In terms of maximum drawdown, CRNC dropped -98.22% vs EDIT's -98.92%.
EDIT currently has the higher Sharpe Ratio (0.03 vs -0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRNC and EDIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer